The prognostic role of WeChat-based instant doctor-patient communication in patients with advanced pancreatic cancer.

IF 3.1 2区 医学 Q2 ONCOLOGY Journal of Cancer Survivorship Pub Date : 2024-12-01 Epub Date: 2023-07-18 DOI:10.1007/s11764-023-01429-7
Hui Tang, Zhou Zhu, Jinrong Ying, Tingting You, Hui Ge, Yuejuan Cheng, Ruixuan Geng, Na Zhou, Wei Qiu, Yuping Ge, Yingyi Wang, Chunmei Bai
{"title":"The prognostic role of WeChat-based instant doctor-patient communication in patients with advanced pancreatic cancer.","authors":"Hui Tang, Zhou Zhu, Jinrong Ying, Tingting You, Hui Ge, Yuejuan Cheng, Ruixuan Geng, Na Zhou, Wei Qiu, Yuping Ge, Yingyi Wang, Chunmei Bai","doi":"10.1007/s11764-023-01429-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with advanced pancreatic ductal adenocarcinoma (PDAC) need timely medical assistance since the emergence of complications due to the disease and antitumor treatment. Studies have confirmed that instant messaging can improve the quality of life and compliance of cancer patients. However, the prognostic role of instant doctor-patient communication based on instant messaging applications in PDAC has not been studied.</p><p><strong>Methods: </strong>Patients with PDAC who received first-line chemotherapy at Peking Union Medical College Hospital between January 2015 and October 2022 were reviewed. We categorized patients into two groups according to whether they received WeChat-based instant doctor-patient communication, and the prognosis and toxicity data between the two groups were compared.</p><p><strong>Results: </strong>A total of 431 PDAC patients were enrolled, of whom 163 had long-term instant communication with their doctors based on WeChat, and 268 did not receive WeChat-based instant communication. There was no significant correlation between WeChat-based communication and first-line chemotherapy overall response rate (14.1% vs. 8.6%, p = 0.074), incidence of grade ≥ 3 adverse events (66.9% vs. 65.7%, p = 0.814) or overall survival (14.7 vs. 13.9 months, p = 0.170) in all enrolled patients. However, patients who received WeChat-based instant communication had a higher completion rate of first-line chemotherapy (42.0% vs. 30.7%, p = 0.023). Consistently, in the patients who developed grade ≥ 3 adverse events (n = 231), those who received WeChat-based instant communication had significantly longer overall survival (17.3 vs. 15.3 months, p = 0.018), even after adjustment for biases.</p><p><strong>Conclusions: </strong>WeChat-based instant doctor-patient communication demonstrated no superiority in improving the efficacy of chemotherapy or preventing chemotherapy toxicity in PDAC patients, but it may contribute to improving the completion rate of chemotherapy and the prognosis in patients who experienced severe adverse events.</p><p><strong>Implications for cancer survivors: </strong>Instant doctor‒patient communication may help to timely and appropriately deal with adverse events and prolong the survival time of patients with PDAC, supporting the promotion of mobile technology in clinical practice.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":"1903-1911"},"PeriodicalIF":3.1000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Survivorship","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11764-023-01429-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with advanced pancreatic ductal adenocarcinoma (PDAC) need timely medical assistance since the emergence of complications due to the disease and antitumor treatment. Studies have confirmed that instant messaging can improve the quality of life and compliance of cancer patients. However, the prognostic role of instant doctor-patient communication based on instant messaging applications in PDAC has not been studied.

Methods: Patients with PDAC who received first-line chemotherapy at Peking Union Medical College Hospital between January 2015 and October 2022 were reviewed. We categorized patients into two groups according to whether they received WeChat-based instant doctor-patient communication, and the prognosis and toxicity data between the two groups were compared.

Results: A total of 431 PDAC patients were enrolled, of whom 163 had long-term instant communication with their doctors based on WeChat, and 268 did not receive WeChat-based instant communication. There was no significant correlation between WeChat-based communication and first-line chemotherapy overall response rate (14.1% vs. 8.6%, p = 0.074), incidence of grade ≥ 3 adverse events (66.9% vs. 65.7%, p = 0.814) or overall survival (14.7 vs. 13.9 months, p = 0.170) in all enrolled patients. However, patients who received WeChat-based instant communication had a higher completion rate of first-line chemotherapy (42.0% vs. 30.7%, p = 0.023). Consistently, in the patients who developed grade ≥ 3 adverse events (n = 231), those who received WeChat-based instant communication had significantly longer overall survival (17.3 vs. 15.3 months, p = 0.018), even after adjustment for biases.

Conclusions: WeChat-based instant doctor-patient communication demonstrated no superiority in improving the efficacy of chemotherapy or preventing chemotherapy toxicity in PDAC patients, but it may contribute to improving the completion rate of chemotherapy and the prognosis in patients who experienced severe adverse events.

Implications for cancer survivors: Instant doctor‒patient communication may help to timely and appropriately deal with adverse events and prolong the survival time of patients with PDAC, supporting the promotion of mobile technology in clinical practice.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于微信的即时医患沟通对晚期胰腺癌患者预后的作用。
背景:晚期胰腺导管腺癌(PDAC)患者需要及时的医疗援助,因为疾病和抗肿瘤治疗会导致并发症的出现。研究证实,即时通讯可以提高癌症患者的生活质量和依从性。然而,基于即时通讯应用的医患即时沟通在 PDAC 中的预后作用尚未得到研究:方法:对 2015 年 1 月至 2022 年 10 月期间在北京协和医院接受一线化疗的 PDAC 患者进行回顾性研究。根据是否接受微信即时医患沟通将患者分为两组,比较两组患者的预后和毒性数据:结果:共纳入 431 例 PDAC 患者,其中 163 例与医生进行了基于微信的长期即时交流,268 例未接受基于微信的即时交流。在所有入组患者中,基于微信的沟通与一线化疗总反应率(14.1% vs. 8.6%,p = 0.074)、≥3级不良事件发生率(66.9% vs. 65.7%,p = 0.814)或总生存期(14.7个月 vs. 13.9个月,p = 0.170)之间无明显相关性。然而,接受微信即时通信的患者完成一线化疗的比例更高(42.0% 对 30.7%,p = 0.023)。同样,在发生≥3级不良事件的患者中(n = 231),即使在调整了偏差后,接受微信即时沟通的患者的总生存期也明显更长(17.3个月 vs. 15.3个月,p = 0.018):结论:基于微信的医患即时沟通在提高 PDAC 患者化疗疗效或预防化疗毒性方面并无优势,但它可能有助于提高化疗完成率,改善出现严重不良事件的患者的预后:医患即时沟通有助于及时、妥善地处理不良事件,延长PDAC患者的生存时间,支持在临床实践中推广移动技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.00
自引率
10.80%
发文量
149
审稿时长
>12 weeks
期刊介绍: Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.
期刊最新文献
Correction: Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease. Fear of cancer recurrence and its predictors among patients with non-small cell lung cancer (NSCLC). Sexual satisfaction in prostate cancer: a multi-group comparison study of treated patients, patients under active surveillance, patients with negative biopsy, and controls. Quality of life assessment in testicular non-seminomatous germ cell tumour survivors. State of research, feasibility, safety, acceptability, and outcomes examined on remotely delivered exercises using technology for older adult with cancer: a scoping review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1